One study used FVB strain erbB2 (HER2) mutant mice with genetic prepositions to mammary tumors and found that when supplied with Lactobacillus reuteri to the gut, the mouse immune system triggered CD4+CD45RBloCD25+ lymphocyte (Treg cells) protective mechanisms to inhibit cancer progression (47). This evidence concerns the gene CD4 and breast cancer.